Skip to content

Fixation of OsseoTi™ Porous Structure Versus PPS (Porous Plasma Spray) Coating on the G7™ Acetabular Component for Primary Total Hip Arthroplasty

Fixation of OsseoTi™ Porous Structure Versus PPS (Porous Plasma Spray) Coating on the G7™ Acetabular Component for Primary Total Hip Arthroplasty: A Single-Blinded Randomized Controlled Trial Evaluating Implant Migration, Acetabular Liner Wear, and Patient Reported Outcome

Status
Active, not recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02316704
Enrollment
98
Registered
2014-12-15
Start date
2014-12-31
Completion date
2027-04-30
Last updated
2021-02-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoarthritis

Brief summary

The primary objective of this project is to investigate, using RSA, acetabular implant migration of the OsseoTi™ G7 acetabular cup in comparison to conventional PPS coated G7 acetabular cup, and compare liner wear of thinnest available E1™ liner, allowing for the largest possible femoral head (36mm-44mm) to E1™ liner holding a 32mm femoral head in the G7 acetabular system with endpoint assessment being performed at the 2 year follow-up.

Interventions

DEVICETHA with G7 PPS coted acetabular component
DEVICETHA with G7 OsseoTi coted acetabular component

Sponsors

Hvidovre University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* • Participants with primary hip osteoarthritis set to receive a primary unilateral uncemented total hip arthroplasty. * Participants must be 18-75 years of age. * Participants must be able to speak and understand Danish (or depending on country where patient is enrolled). * Participants must be able to give informed consent and be cognitively intact. * Participants must be expected to be able to complete all postoperative controls. * Participants must not have severe comorbidities, ASA-score ≤ 3.

Exclusion criteria

* Terminal illness. * Rheumatoid arthritis. * Previous fracture of the hip. * Osteonecrosis of the hip. * Previous infection of the hip. * Severe bony deformity warranting the use of non-standard implants. * Metastasis in the periarticular bone or proximal femur. * Female patients that are pregnant or planning pregnancy during follow-up period * If bone stock or femoral canal type, assessed on preoperative x-ray, warrants the use of cemented fixation. * Documented osteoporosis with patient in active medical treatment. * Comorbidity with altered pain perception (e.g. DM with neuropathy). * Participants that develop deep infection in the follow-up period are excluded from the project.

Design outcomes

Primary

MeasureTime frameDescription
RSA migration in 3 dimentions of the acetabular components as measured by Radiostereometric analysis, RSA.2 yearRadiostereometric analysis, RSA, is an accurate technique for measuring small relative motions from sequential sets of radiographs over time and has been used to measure polyethylene wear and implant migration. Measurements are performed in microns.

Countries

Denmark, Sweden

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026